SVP & Project Lead, Core competencies for the future of Merck KGaA Healthcare business, Global Marketing & Strategy, Merck KGaA
“PASSION for the project, day –to-day INNOVATION in all areas, a cohesive TEAM with shared VALUES; these are the best ingredients for professional success”
As the former Head of Global Market Access and Pricing for EMD Serono from 2012-2017, Ana was responsible for developing a global holistic market access strategy, and robust pricing and reimbursement strategies for EMD Serono products. This includes market access plans and guidelines, price analytics, launch pricing and price band setting, as well as acting as the Center of Functional Excellence in Market Access and Pricing.
She started her career in the biotechnology company Serono as Director of Government Affairs in February 2003, managing the development of this area of the company for Spain and Portugal. In June 2007, after the acquisition of Serono by Merck KGaA, Darmstadt, Germany, Ana was named Corporate Affairs Director of Merck S.L., the Spanish subsidiary of Merck KGaA, Darmstadt, Germany, in charge of Communications, Innovation & Continuous Improvement, Government Affairs, Market Access, Regulatory Affairs, & Commercial Compliance, a position she held until September 2012, when she was transferred to the Boston office in Rockland, Massachusetts and appointed Head of Market Access and Pricing. She has also served as Managing Director of the Fundación Salud 2000 (2004-2011), a not-for-profit organization dedicated to the promotion of research.
With 17 years of experience in the healthcare sector, Ana worked as a teacher and researcher at the Universidad Complutense de Madrid (1995-1999), Senior Consultant in HealthCare Strategy at Arthur Andersen (2000-2003), where she worked on numerous projects in the areas of government affairs, market access, strategic positioning and management of healthcare institutions, balanced scorecard implementation, processes redesign and healthcare institutions reorganizations.
PhD in Pharmacy in the areas of genetics and immunology by the UCM (2000), Ana holds a degree in Pharmacy by the UCM (1995), an Executive Master's Degree in Healthcare Institutions Management by Arthur Andersen (2001), and an Executive Degree in General Management by IESE (2009). She graduated as a bachelor and doctorate with high honor. Ana is also professor in the Instituto de Empresa Business School, and founder of the Executive Education Program on Institutional Relations & Market Access (EERIMAS) in Spain.